The BioFire® RP2.1 Panel Did Not Identify Concurrent Respiratory Virus Infection in Adults with Variable SARS-CoV-2 Disease Severity and Infection Duration

SARS-CoV-2 emerged in 2019 and rapidly surged into a global pandemic. The rates of concurrent infection with other respiratory pathogens and the effects of possible coinfections on the severity of COVID-19 cases and the length of viral infection are not well defined. In this retrospective study, nas...

Full description

Saved in:
Bibliographic Details
Main Authors: Kendra M. Quicke, Bridget A. Baxter, Sophia Stromberg, Emily N. Gallichotte, Emily Fitzmeyer, Michael C. Young, Kristy L. Pabilonia, Nicole Ehrhart, Julie Dunn, Gregory D. Ebel, Elizabeth P. Ryan
Format: Article
Language:English
Published: Wiley 2022-01-01
Series:Advances in Virology
Online Access:http://dx.doi.org/10.1155/2022/1378482
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1850167842913124352
author Kendra M. Quicke
Bridget A. Baxter
Sophia Stromberg
Emily N. Gallichotte
Emily Fitzmeyer
Michael C. Young
Kristy L. Pabilonia
Nicole Ehrhart
Julie Dunn
Gregory D. Ebel
Elizabeth P. Ryan
author_facet Kendra M. Quicke
Bridget A. Baxter
Sophia Stromberg
Emily N. Gallichotte
Emily Fitzmeyer
Michael C. Young
Kristy L. Pabilonia
Nicole Ehrhart
Julie Dunn
Gregory D. Ebel
Elizabeth P. Ryan
author_sort Kendra M. Quicke
collection DOAJ
description SARS-CoV-2 emerged in 2019 and rapidly surged into a global pandemic. The rates of concurrent infection with other respiratory pathogens and the effects of possible coinfections on the severity of COVID-19 cases and the length of viral infection are not well defined. In this retrospective study, nasopharyngeal swab samples collected in Colorado between March 2020 and May 2021 from SARS-CoV-2 PCR-positive individuals were tested for a panel of 21 additional respiratory pathogens, including 17 viral and 4 bacterial pathogens. We detected significant positive correlations between levels of SARS-CoV-2 RNA and infectious virus titers for both cohorts, as well as a positive correlation between viral RNA levels and disease severity scores for one cohort. We hypothesized that severe COVID-19 cases and longer SARS-CoV-2 infections may be associated with concurrent respiratory infections. Only one individual exhibited evidence of a concurrent infection- SARS -CoV-2 and human rhinovirus/enterovirus- leading us to conclude that viral respiratory coinfections were uncommon during this time and thus not responsible for the variations in disease severity and infection duration observed in the two cohorts examined. Mask wearing and other public health measures were imposed in Colorado during the time of collection and likely contributed to low rates of coinfection.
format Article
id doaj-art-dfeb9ba7b8d94d1f969d0252857621b7
institution OA Journals
issn 1687-8647
language English
publishDate 2022-01-01
publisher Wiley
record_format Article
series Advances in Virology
spelling doaj-art-dfeb9ba7b8d94d1f969d0252857621b72025-08-20T02:21:07ZengWileyAdvances in Virology1687-86472022-01-01202210.1155/2022/1378482The BioFire® RP2.1 Panel Did Not Identify Concurrent Respiratory Virus Infection in Adults with Variable SARS-CoV-2 Disease Severity and Infection DurationKendra M. Quicke0Bridget A. Baxter1Sophia Stromberg2Emily N. Gallichotte3Emily Fitzmeyer4Michael C. Young5Kristy L. Pabilonia6Nicole Ehrhart7Julie Dunn8Gregory D. Ebel9Elizabeth P. Ryan10Arthropod-Borne and Infectious Diseases LaboratoryDepartment of Environmental and Radiological Health SciencesDepartment of Environmental and Radiological Health SciencesArthropod-Borne and Infectious Diseases LaboratoryArthropod-Borne and Infectious Diseases LaboratoryArthropod-Borne and Infectious Diseases LaboratoryArthropod-Borne and Infectious Diseases LaboratoryColumbine Health Systems Center for Healthy Aging and Department of Clinical SciencesUniversity of Colorado HealthArthropod-Borne and Infectious Diseases LaboratoryDepartment of Environmental and Radiological Health SciencesSARS-CoV-2 emerged in 2019 and rapidly surged into a global pandemic. The rates of concurrent infection with other respiratory pathogens and the effects of possible coinfections on the severity of COVID-19 cases and the length of viral infection are not well defined. In this retrospective study, nasopharyngeal swab samples collected in Colorado between March 2020 and May 2021 from SARS-CoV-2 PCR-positive individuals were tested for a panel of 21 additional respiratory pathogens, including 17 viral and 4 bacterial pathogens. We detected significant positive correlations between levels of SARS-CoV-2 RNA and infectious virus titers for both cohorts, as well as a positive correlation between viral RNA levels and disease severity scores for one cohort. We hypothesized that severe COVID-19 cases and longer SARS-CoV-2 infections may be associated with concurrent respiratory infections. Only one individual exhibited evidence of a concurrent infection- SARS -CoV-2 and human rhinovirus/enterovirus- leading us to conclude that viral respiratory coinfections were uncommon during this time and thus not responsible for the variations in disease severity and infection duration observed in the two cohorts examined. Mask wearing and other public health measures were imposed in Colorado during the time of collection and likely contributed to low rates of coinfection.http://dx.doi.org/10.1155/2022/1378482
spellingShingle Kendra M. Quicke
Bridget A. Baxter
Sophia Stromberg
Emily N. Gallichotte
Emily Fitzmeyer
Michael C. Young
Kristy L. Pabilonia
Nicole Ehrhart
Julie Dunn
Gregory D. Ebel
Elizabeth P. Ryan
The BioFire® RP2.1 Panel Did Not Identify Concurrent Respiratory Virus Infection in Adults with Variable SARS-CoV-2 Disease Severity and Infection Duration
Advances in Virology
title The BioFire® RP2.1 Panel Did Not Identify Concurrent Respiratory Virus Infection in Adults with Variable SARS-CoV-2 Disease Severity and Infection Duration
title_full The BioFire® RP2.1 Panel Did Not Identify Concurrent Respiratory Virus Infection in Adults with Variable SARS-CoV-2 Disease Severity and Infection Duration
title_fullStr The BioFire® RP2.1 Panel Did Not Identify Concurrent Respiratory Virus Infection in Adults with Variable SARS-CoV-2 Disease Severity and Infection Duration
title_full_unstemmed The BioFire® RP2.1 Panel Did Not Identify Concurrent Respiratory Virus Infection in Adults with Variable SARS-CoV-2 Disease Severity and Infection Duration
title_short The BioFire® RP2.1 Panel Did Not Identify Concurrent Respiratory Virus Infection in Adults with Variable SARS-CoV-2 Disease Severity and Infection Duration
title_sort biofire r rp2 1 panel did not identify concurrent respiratory virus infection in adults with variable sars cov 2 disease severity and infection duration
url http://dx.doi.org/10.1155/2022/1378482
work_keys_str_mv AT kendramquicke thebiofirerp21paneldidnotidentifyconcurrentrespiratoryvirusinfectioninadultswithvariablesarscov2diseaseseverityandinfectionduration
AT bridgetabaxter thebiofirerp21paneldidnotidentifyconcurrentrespiratoryvirusinfectioninadultswithvariablesarscov2diseaseseverityandinfectionduration
AT sophiastromberg thebiofirerp21paneldidnotidentifyconcurrentrespiratoryvirusinfectioninadultswithvariablesarscov2diseaseseverityandinfectionduration
AT emilyngallichotte thebiofirerp21paneldidnotidentifyconcurrentrespiratoryvirusinfectioninadultswithvariablesarscov2diseaseseverityandinfectionduration
AT emilyfitzmeyer thebiofirerp21paneldidnotidentifyconcurrentrespiratoryvirusinfectioninadultswithvariablesarscov2diseaseseverityandinfectionduration
AT michaelcyoung thebiofirerp21paneldidnotidentifyconcurrentrespiratoryvirusinfectioninadultswithvariablesarscov2diseaseseverityandinfectionduration
AT kristylpabilonia thebiofirerp21paneldidnotidentifyconcurrentrespiratoryvirusinfectioninadultswithvariablesarscov2diseaseseverityandinfectionduration
AT nicoleehrhart thebiofirerp21paneldidnotidentifyconcurrentrespiratoryvirusinfectioninadultswithvariablesarscov2diseaseseverityandinfectionduration
AT juliedunn thebiofirerp21paneldidnotidentifyconcurrentrespiratoryvirusinfectioninadultswithvariablesarscov2diseaseseverityandinfectionduration
AT gregorydebel thebiofirerp21paneldidnotidentifyconcurrentrespiratoryvirusinfectioninadultswithvariablesarscov2diseaseseverityandinfectionduration
AT elizabethpryan thebiofirerp21paneldidnotidentifyconcurrentrespiratoryvirusinfectioninadultswithvariablesarscov2diseaseseverityandinfectionduration
AT kendramquicke biofirerp21paneldidnotidentifyconcurrentrespiratoryvirusinfectioninadultswithvariablesarscov2diseaseseverityandinfectionduration
AT bridgetabaxter biofirerp21paneldidnotidentifyconcurrentrespiratoryvirusinfectioninadultswithvariablesarscov2diseaseseverityandinfectionduration
AT sophiastromberg biofirerp21paneldidnotidentifyconcurrentrespiratoryvirusinfectioninadultswithvariablesarscov2diseaseseverityandinfectionduration
AT emilyngallichotte biofirerp21paneldidnotidentifyconcurrentrespiratoryvirusinfectioninadultswithvariablesarscov2diseaseseverityandinfectionduration
AT emilyfitzmeyer biofirerp21paneldidnotidentifyconcurrentrespiratoryvirusinfectioninadultswithvariablesarscov2diseaseseverityandinfectionduration
AT michaelcyoung biofirerp21paneldidnotidentifyconcurrentrespiratoryvirusinfectioninadultswithvariablesarscov2diseaseseverityandinfectionduration
AT kristylpabilonia biofirerp21paneldidnotidentifyconcurrentrespiratoryvirusinfectioninadultswithvariablesarscov2diseaseseverityandinfectionduration
AT nicoleehrhart biofirerp21paneldidnotidentifyconcurrentrespiratoryvirusinfectioninadultswithvariablesarscov2diseaseseverityandinfectionduration
AT juliedunn biofirerp21paneldidnotidentifyconcurrentrespiratoryvirusinfectioninadultswithvariablesarscov2diseaseseverityandinfectionduration
AT gregorydebel biofirerp21paneldidnotidentifyconcurrentrespiratoryvirusinfectioninadultswithvariablesarscov2diseaseseverityandinfectionduration
AT elizabethpryan biofirerp21paneldidnotidentifyconcurrentrespiratoryvirusinfectioninadultswithvariablesarscov2diseaseseverityandinfectionduration